These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Circulating antibodies against M-type phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in Chinese patients with membranous nephropathy. Tian C; Li L; Liu T; Qu X; Qiu Y Int Urol Nephrol; 2019 Aug; 51(8):1371-1377. PubMed ID: 31227982 [TBL] [Abstract][Full Text] [Related]
3. Genetic determinants of the development and course of membranous nephropathy. Kamyshova ES; Bobkova IN; Gorelova IA; Каkhsurueva PA; Filatova EE Ter Arkh; 2018 Jun; 90(6):105-111. PubMed ID: 30701913 [TBL] [Abstract][Full Text] [Related]
4. Clinical and Histological Features of Phospholipase A2 Receptor-Associated and Thrombospondin Type-I Domain-containing 7A-Associated Idiopathic Membranous Nephropathy: A Single Center Retrospective Study from China. Zhang D; Zou J; Zhang C; Zhang W; Lin F; Jiang G Med Sci Monit; 2018 Jul; 24():5076-5083. PubMed ID: 30032157 [TBL] [Abstract][Full Text] [Related]
5. Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its Role. Liu W; Gao C; Dai H; Zheng Y; Dong Z; Gao Y; Liu F; Zhang Z; Liu Z; Liu W; Liu B; Liu Q; Shi J Front Immunol; 2019; 10():1809. PubMed ID: 31447839 [TBL] [Abstract][Full Text] [Related]
6. Associations between m-type phospholipase A2 receptor,human leukocyte antigen gene polymorphisms and idiopathic membranous nephropathy. Liu X; Xu W; Yu C; Wang M; Liu R; Xie R Bioengineered; 2021 Dec; 12(1):8833-8844. PubMed ID: 34607530 [TBL] [Abstract][Full Text] [Related]
7. Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain. L'Imperio V; Pieruzzi F; Sinico RA; Nebuloni M; Granata A; Smith A; Radice A; Pagni F J Nephrol; 2018 Aug; 31(4):543-550. PubMed ID: 29626294 [TBL] [Abstract][Full Text] [Related]
8. Clinical significance of M Gong Z; Yuan S; Zhu X; Wang Y; Yu F; Yang D; Xu X; Liu H; Li J; Sun L Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jun; 45(6):693-700. PubMed ID: 32879127 [TBL] [Abstract][Full Text] [Related]
9. Circulating Antibodies against Thrombospondin Type-I Domain-Containing 7A in Chinese Patients with Idiopathic Membranous Nephropathy. Wang J; Cui Z; Lu J; Probst C; Zhang YM; Wang X; Qu Z; Wang F; Meng LQ; Cheng XY; Liu G; Debiec H; Ronco P; Zhao MH Clin J Am Soc Nephrol; 2017 Oct; 12(10):1642-1651. PubMed ID: 28801527 [TBL] [Abstract][Full Text] [Related]
10. Meta-Analysis of the Diagnostic Efficiency of THSD7A-AB for the Diagnosis of Idiopathic Membranous Nephropathy. Liu Y; Zheng S; Ma C; Lian Y; Zheng X; Guan P; Wang B; Gong X; Gao F; Liang L; Xu D Glob Chall; 2020 Nov; 4(11):1900099. PubMed ID: 33163223 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases. Radice A; Pieruzzi F; Trezzi B; Ghiggeri G; Napodano P; D'Amico M; Stellato T; Brugnano R; Ravera F; Rolla D; Pesce G; Giovenzana ME; Londrino F; Cantaluppi V; Pregnolato F; Volpi A; Rombolà G; Moroni G; Ortisi G; Sinico RA J Nephrol; 2018 Apr; 31(2):271-278. PubMed ID: 29081027 [TBL] [Abstract][Full Text] [Related]
12. Membranous nephropathy: A ten-year journey of discoveries. Cai Q; Hendricks AR Semin Diagn Pathol; 2020 May; 37(3):116-120. PubMed ID: 32061439 [TBL] [Abstract][Full Text] [Related]
13. Revisiting immunological and clinical aspects of membranous nephropathy. Nieto-Gañán I; Iturrieta-Zuazo I; Rita C; Carrasco-Sayalero Á Clin Immunol; 2022 Apr; 237():108976. PubMed ID: 35276323 [TBL] [Abstract][Full Text] [Related]
14. [Clinical Significance of Thrombospondin Type 1 Domain-Containing 7A and Neural Epidermal Growth Factor-Like 1 Protein in M-Type Phospholipase A2 Receptor-Negative Membranous Nephropathy]. Tang XL; DU YY; Yu J; Ye T; Zhu H; Chen YF; Li XH Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Apr; 45(2):235-244. PubMed ID: 37157070 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic utility of serum and urine biomarkers in idiopathic membranous nephropathy: a systematic review and meta-analysis. Gao D; Lu LP; Zhao ZG Int Urol Nephrol; 2023 Oct; 55(10):2517-2526. PubMed ID: 36961513 [TBL] [Abstract][Full Text] [Related]
16. Membranous Nephropathy: A Journey From Bench to Bedside. Francis JM; Beck LH; Salant DJ Am J Kidney Dis; 2016 Jul; 68(1):138-47. PubMed ID: 27085376 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of Enhanced Granular Expression of Thrombospondin Type-1 Domain-Containing 7A in the Glomeruli of Japanese Patients with Idiopathic Membranous Nephropathy. Iwakura T; Ohashi N; Kato A; Baba S; Yasuda H PLoS One; 2015; 10(9):e0138841. PubMed ID: 26393352 [TBL] [Abstract][Full Text] [Related]
18. An update on clinical significance of use of THSD7A in diagnosing idiopathic membranous nephropathy: a systematic review and meta-analysis of THSD7A in IMN. Ren S; Wu C; Zhang Y; Wang AY; Li G; Wang L; Hong D Ren Fail; 2018 Nov; 40(1):306-313. PubMed ID: 29623759 [TBL] [Abstract][Full Text] [Related]
19. Clinical value of renal phospholipase A2 receptor deposit in the prognosis evaluation and treatment options of idiopathic membranous nephropathy: A retrospective cohort study. Xie Z; Dong W; Li Z; Chen Y; Song L; Li R; Wu Y; Fu L; Liang H; Tao Y; Xie J; Wang W; Liu S; Ye Z; Shi W; Liang X Nephrology (Carlton); 2020 Mar; 25(3):219-229. PubMed ID: 31900967 [TBL] [Abstract][Full Text] [Related]